Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slim Fourati

Showing results (121-130 of 185) with videos related to

Pageof 19
Sort By:
Nature Immunology|November 1, 2022
Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccinationSlim Fourati, Lewis E Tomalin, Matthew P Mulè, et al.
Elife|February 4, 2015
Mucosal effects of tenofovir 1% gelFlorian Hladik, Adam Burgener, Lamar Ballweber, et al.
Elife|March 25, 2015
Correction: Musosal effects for tenofovir 1% gelFlorian Hladik, Adam Burgener, Lamar Ballweber, et al.
Plos Pathogens|March 29, 2021
Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19Christophe Rodriguez, Nicolas de Prost, Slim Fourati, et al.
Elife|September 17, 2021
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1Shida Shangguan, Philip K Ehrenberg, Aviva Geretz, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 UsageClaudia Alteri, Matteo Surdo, Maria Concetta Bellocchi, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2015
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patientsSlim Fourati, Charlotte Charpentier, Corinne Amiel, et al.
Nature Immunology|November 1, 2022
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responsesThomas Hagan, Bram Gerritsen, Lewis E Tomalin, et al.
Hepatology (Baltimore, Md.)|April 10, 2019
Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape VariantsSanne Brun Jensen, Ulrik Fahnøe, Long V Pham, et al.
Nature Communications|February 22, 2019
Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccineSlim Fourati, Susan Pereira Ribeiro, Filipa Blasco Tavares Pereira Lopes, et al.
Pageof 19

Showing results (121-130 of 185) with videos related to

Sort By:
Pageof 19
Nature Immunology|November 1, 2022
Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccinationSlim Fourati, Lewis E Tomalin, Matthew P Mulè, et al.
Elife|February 4, 2015
Mucosal effects of tenofovir 1% gelFlorian Hladik, Adam Burgener, Lamar Ballweber, et al.
Elife|March 25, 2015
Correction: Musosal effects for tenofovir 1% gelFlorian Hladik, Adam Burgener, Lamar Ballweber, et al.
Plos Pathogens|March 29, 2021
Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19Christophe Rodriguez, Nicolas de Prost, Slim Fourati, et al.
Elife|September 17, 2021
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1Shida Shangguan, Philip K Ehrenberg, Aviva Geretz, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 UsageClaudia Alteri, Matteo Surdo, Maria Concetta Bellocchi, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2015
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patientsSlim Fourati, Charlotte Charpentier, Corinne Amiel, et al.
Nature Immunology|November 1, 2022
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responsesThomas Hagan, Bram Gerritsen, Lewis E Tomalin, et al.
Hepatology (Baltimore, Md.)|April 10, 2019
Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape VariantsSanne Brun Jensen, Ulrik Fahnøe, Long V Pham, et al.
Nature Communications|February 22, 2019
Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccineSlim Fourati, Susan Pereira Ribeiro, Filipa Blasco Tavares Pereira Lopes, et al.
Pageof 19